Allogene stock downgraded by JPMorgan on concerns over program changes By Investing.com - Stock Watch Index

Allogene stock downgraded by JPMorgan on concerns over program changes By Investing.com

October 10, 2025

Allogene stock downgraded by JPMorgan on concerns over program changes

Search

RECENT PRESS RELEASES

Allogene stock downgraded by JPMorgan on concerns over program changes By Investing.com

SWI Editorial Staff2025-10-10T02:41:10-07:00October 10, 2025|

JPMorgan downgrades Pliant Therapeutics stock rating to Underweight from Neutral By Invest

SWI Editorial Staff2025-10-10T02:40:51-07:00October 10, 2025|

JPMorgan downgrades Doximity stock to Underweight on valuation concerns By Investing.com

SWI Editorial Staff2025-10-10T02:40:38-07:00October 10, 2025|

European shares muted as investors eye French political upheaval By Investing.com

SWI Editorial Staff2025-10-10T02:40:22-07:00October 10, 2025|

Mizuho initiates Viking Holdings stock with Underperform rating By Investing.com

SWI Editorial Staff2025-10-10T02:39:57-07:00October 10, 2025|

Citizens reiterates Market Outperform rating on DocuSign stock at $124 By Investing.com

SWI Editorial Staff2025-10-10T02:39:40-07:00October 10, 2025|

Related Post